FIELD: biotechnology.
SUBSTANCE: described is a vaccine containing an active substance and a target additive. As an active substance, the vaccine contains a mixture of inactivated and purified antigen material from the "Sheba" strain of feline panleukopenia virus, Parvoviridae family, Protoparvovirus genus, Carnivore protoparvovirus 1 species, from inactivated and purified antigenic material from feline calicivirus "Pers" strain, Caliciviridae family, Vesivirus genus, Feline calicivirus species, from inactivated and purified antigenic material from the feline calicivirus "Fauna" strain, Caliciviridae family, Vesivirus genus, Feline calicivirus species, from inactivated and purified antigenic material from "Laurel" strain of viral rhinotracheitis of cats, Herpesviridae family, Varicellovirus genus, Alpaherpesvirus 1 species, from inactivated and purified antigenic material from strain "ARRIAH" of rabies virus of Rhabdoviridae family and as target additives 3 % aluminium hydroxide gel, taken in an effective ratio and in amounts providing protective immune activity of each antigen in the body of cats after administration of the target preparation.
EFFECT: expansion of the range of associated vaccines used for the prevention of panleukopenia, calicivirus, viral rhinotracheitis and rabies, obtaining a stable vaccine, high antigenic and immunogenic activity of the vaccine, as well as intensified immunity in vaccinated animals due to production of vaccine components with a full spectrum of antigens.
7 cl, 4 dwg, 4 tbl, 4 ex
